2.9(top 20%)
impact factor
3.0K(top 10%)
papers
41.7K(top 10%)
citations
62(top 10%)
h-index
3.0(top 20%)
impact factor
3.8K
all documents
45.0K
doc citations
99(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Photodynamic therapy of cancer. Basic principles and applicationsClinical and Translational Oncology2008611
2Natural products as leads to anticancer drugsClinical and Translational Oncology2007556
3Survival in glioblastoma: a review on the impact of treatment modalitiesClinical and Translational Oncology2016476
4Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinomaClinical and Translational Oncology2010273
5Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical researchClinical and Translational Oncology2012239
6Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stageClinical and Translational Oncology2005221
7Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancerClinical and Translational Oncology2012216
8Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancerClinical and Translational Oncology2011201
9Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic reviewClinical and Translational Oncology2010185
10Cancer incidence in Spain, 2015Clinical and Translational Oncology2017169
11Ki67 targeted strategies for cancer therapyClinical and Translational Oncology2018167
12Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patientsClinical and Translational Oncology2008156
13Emerging roles of aerobic glycolysis in breast cancerClinical and Translational Oncology2020140
14Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategiesClinical and Translational Oncology2010138
15Altered expression of piRNAs and their relation with clinicopathologic features of breast cancerClinical and Translational Oncology2013131
16Cell signalling: growth factors and tyrosine kinase receptorsClinical and Translational Oncology2006122
17Aberrant expression of UCA1 in gastric cancer and its clinical significanceClinical and Translational Oncology2015117
18The new function of circRNA: translationClinical and Translational Oncology2020117
19Mouse models in oncogenesis and cancer therapyClinical and Translational Oncology2006116
20Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological featuresClinical and Translational Oncology2015116
21Oxycodone: a pharmacological and clinical reviewClinical and Translational Oncology2007114
22Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patientsClinical and Translational Oncology2018112
23Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expressionClinical and Translational Oncology2013110
24SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)Clinical and Translational Oncology2019110
25Novel insight into the role of GAPDH playing in tumorClinical and Translational Oncology2013105
26Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeuticsClinical and Translational Oncology2018105
27Nutritional support and parenteral nutrition in cancer patients: an expert consensus reportClinical and Translational Oncology2018104
28Wnt signalling and cancer stem cellsClinical and Translational Oncology2009100
29Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancerClinical and Translational Oncology200899
30High throughput screening in drug discoveryClinical and Translational Oncology200698
31Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysisClinical and Translational Oncology201698
32The EMT signaling pathways in endometrial carcinomaClinical and Translational Oncology201295
33Tumor-associated macrophages in cancersClinical and Translational Oncology201695
34Mediterranean diet, olive oil and cancerClinical and Translational Oncology200693
35Notch signalling in cancer stem cellsClinical and Translational Oncology200989
36Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategiesClinical and Translational Oncology201789
37Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycleClinical and Translational Oncology201488
38Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitizationClinical and Translational Oncology201988
39Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapyClinical and Translational Oncology201887
40MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cellsClinical and Translational Oncology201486
41Radiosensitization by gold nanoparticlesClinical and Translational Oncology201385
42Protein kinases and phosphatases as therapeutic targets in cancerClinical and Translational Oncology200684
43SEOM clinical guidelines in Hereditary Breast and ovarian cancerClinical and Translational Oncology201582
44The role of iron in tumour cell proliferationClinical and Translational Oncology201181
45The role of immunotherapy in small cell lung cancerClinical and Translational Oncology201981
46Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in MadridClinical and Translational Oncology202081
47Renal cell carcinoma in pregnancy: a rare coexistenceClinical and Translational Oncology201480
48Giant cell tumour of bone: new treatments in developmentClinical and Translational Oncology201577
49Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancerClinical and Translational Oncology201175
50Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancerClinical and Translational Oncology201775